DE69824358D1 - Peptidfragment von LALF mit antiviraler Wirkung - Google Patents

Peptidfragment von LALF mit antiviraler Wirkung

Info

Publication number
DE69824358D1
DE69824358D1 DE69824358T DE69824358T DE69824358D1 DE 69824358 D1 DE69824358 D1 DE 69824358D1 DE 69824358 T DE69824358 T DE 69824358T DE 69824358 T DE69824358 T DE 69824358T DE 69824358 D1 DE69824358 D1 DE 69824358D1
Authority
DE
Germany
Prior art keywords
peptide
lalf
hep
induce
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69824358T
Other languages
English (en)
Other versions
DE69824358T2 (de
Inventor
Vallespi Maribel Guerra
Jesus Arana Rosainz Manuel De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centro de Ingenieria Genetica y Biotecnologia CIGB
Original Assignee
Centro de Ingenieria Genetica y Biotecnologia CIGB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro de Ingenieria Genetica y Biotecnologia CIGB filed Critical Centro de Ingenieria Genetica y Biotecnologia CIGB
Application granted granted Critical
Publication of DE69824358D1 publication Critical patent/DE69824358D1/de
Publication of DE69824358T2 publication Critical patent/DE69824358T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69824358T 1997-09-29 1998-09-29 Peptidfragment von LALF mit antiviraler Wirkung Expired - Fee Related DE69824358T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU10697 1997-09-29
CU1997106A CU22700A1 (es) 1997-09-29 1997-09-29 Formulación farmacéutica anti-viral que contiene un péptido de la proteína factor anti-lps de limulus y su uso

Publications (2)

Publication Number Publication Date
DE69824358D1 true DE69824358D1 (de) 2004-07-15
DE69824358T2 DE69824358T2 (de) 2005-06-09

Family

ID=5459370

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69824358T Expired - Fee Related DE69824358T2 (de) 1997-09-29 1998-09-29 Peptidfragment von LALF mit antiviraler Wirkung

Country Status (10)

Country Link
US (2) US6191114B1 (de)
EP (1) EP0905141B1 (de)
CN (1) CN1218057A (de)
AT (1) ATE268784T1 (de)
CU (1) CU22700A1 (de)
DE (1) DE69824358T2 (de)
DK (1) DK0905141T3 (de)
ES (1) ES2223105T3 (de)
PT (1) PT905141E (de)
SI (1) SI0905141T1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040199099A1 (en) * 1998-07-10 2004-10-07 Matson James R Hemofiltration systems, methods and devices used to treat inflammatory mediator related disease
US6592869B2 (en) 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
PT1212045T (pt) 1999-08-24 2016-11-22 Abic Biological Laboratories Ltd Composição de vacina e método de utilização da mesma
US7291122B2 (en) * 2000-03-24 2007-11-06 Immunocept, L.L.C. Hemofiltration methods for treatment of diseases in a mammal
US6787040B2 (en) * 2000-05-16 2004-09-07 Immunocept, L.L.C. Method and system for colloid exchange therapy
AT410635B (de) 2000-10-18 2003-06-25 Cistem Biotechnologies Gmbh Vakzin-zusammensetzung
US20060129082A1 (en) * 2002-08-13 2006-06-15 Jacek Rozga Selective plasma exchange therapy
CU23389B6 (es) * 2005-12-29 2009-07-16 Ct Ingenieria Genetica Biotech Combinación farmacéutica citoprotectora, útil en la prevención y tratamiento del síndrome de respuesta inflamatoria sistémica
CU23582A1 (es) 2006-02-24 2010-10-30 Ct Ingenieria Genetica Biotech Péptidos con capacidad anti-tumoral e inmunomoduladora
EP2108372A1 (de) * 2008-04-09 2009-10-14 Forschungszentrum Borstel Leibniz-Zentrum für Medizin und Biowissenschaften Neue antimikrobielle Peptide
CN113563427B (zh) * 2021-06-02 2022-02-01 北京师范大学珠海校区 抗菌短肽lbd-s及其应用和药物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006892A (en) 1991-05-16 1992-12-30 Associates Of Cape Cod, Inc. Endotoxin binding and neutralizing protein and uses thereof
WO1995005393A2 (en) * 1993-08-18 1995-02-23 Morphosys Gesellschaft Für Proteinoptimierung Mbh Lipopolysaccharide-binding and neutralizing peptides
US5780429A (en) * 1995-12-22 1998-07-14 Marine Biological Laboratory Anti-LPS factor from horseshoe crabs and methods of use

Also Published As

Publication number Publication date
EP0905141A1 (de) 1999-03-31
ATE268784T1 (de) 2004-06-15
PT905141E (pt) 2004-10-29
CU22700A1 (es) 2001-07-31
DK0905141T3 (da) 2004-10-25
DE69824358T2 (de) 2005-06-09
SI0905141T1 (en) 2004-12-31
US6632793B1 (en) 2003-10-14
CN1218057A (zh) 1999-06-02
ES2223105T3 (es) 2005-02-16
EP0905141B1 (de) 2004-06-09
US6191114B1 (en) 2001-02-20

Similar Documents

Publication Publication Date Title
DE69824358D1 (de) Peptidfragment von LALF mit antiviraler Wirkung
ATE63748T1 (de) Enzymwiderstandsfaehige immunomodulatorische peptide.
TR200001228T2 (tr) T yardımcı hücre tür 2 kökenli bağışıklık hastalıklarının retinoit antagonistlerle tedavisi
MX7531E (es) Proceso biotecnologico para alterar la proliferacion y/o el desarrollo de cultivos tisulares
LV12038A (lv) Panemieni un lidzekli cilveka seksualas reakcijas modulesanai
ATE140483T1 (de) Natürlicher killerzellen-stimulationsfaktor
ATE531382T1 (de) Behandlungsmethoden von entzündungskrankheiten mit spezifisch an menschliches angiopoietin-2 bindenden wirkstoffen
DE69812941D1 (de) Verwendung von mikropartikeln mit adsorbiertem antigen zur stimulierung der immunabwehr
ATE286510T1 (de) In der behandlung von il4 auslösenden krankheiten nützliche rekombinante il4 antikörper
DE3582973D1 (de) Neues derivat des humangammainterferon-polypeptids.
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
DE3683430D1 (de) Einen menschlichen granulozytkoloniereizfaktor fuer die behandlung von leukopenien enthaltende pharmazeutische zubereitung.
SE8700203D0 (sv) Pyroglutamide derivatives
MX170929B (es) Empleo de substancias antigenicas para la profilaxis o la terapia de transtornos y enfermedades en el conducto digestivo de animales y humanos
KR870004971A (ko) 티아졸론 및 이의 제조방법
IT7967029A0 (it) Amminoderivati della pirazolo i 5 as triazina particolarmente utili in terapia e procedimento per la loropreparazione
DE69127975T2 (de) Impfstoffe
ATE30238T1 (de) N-acylderivate von peptiden, ihre herstellung und verwendung bei der bekaempfung von krankheiten und mittel dafuer.
DE59106997D1 (de) Ancrod ähnliche proteine, ihre herstellung und verwendung.
DE69003216T2 (de) Verwendung von somatostatin.
ES290272U (es) Pulsera
KR900019561A (ko) 인체 과립성 백혈구의 콜로니 자극인자
ITAN920032A1 (it) Utensile terapeutico in grado di esercitare stimolazioni vibratorie localizzate su ridotte aree della muscolatura umana
IT8920643A0 (it) Impiego della farina di fibra di nocciola in campo dietetico per l'ottenimento di effetti dimagranti e di migliorato assorbimento intestinale degli amminoacidi.
BR8306869A (pt) Valvula cardiaca mecanica implantavel em seres humanos

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee